Borderline ovarian tumors (BOTs) are a type of low malignant potential tumor that is typically
associated with better outcomes than ovarian cancer. Indeed, its 10-year survival rate is as …

Tumors of the epithelial surface account for about 80% of all ovarian neoplasms and exhibit
a heterogeneous histological classification affecting survival. Tumors of low malignant …

Since their original description in 1929, our knowledge of the natural history and molecular
pathology of borderline ovarian tumors (BOTs) has advanced most dramatically over the last …

Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms,
intermediate between benign and malignant categories. Since BOT were first identified> 40 …

This article summarizes key issues for future research on borderline ovarian tumors that
emerged at a National Cancer Institute-sponsored Borderline Ovarian Tumor Workshop held …

Background Borderline ovarian tumors (BOT) are epithelial tumors of the ovaries with both
malignant and non-malignant aspects. On the one hand, they are characterized by cellular …

Abstract Learning Objectives After completing this course, the reader will be able to:
Compare the epidemiologic and reproductive risk factors in BOTs with those in ovarian …

Our growing understanding of the relatively benign natural history of borderline ovarian
tumors has allowed us to be more conservative in their surgical management, preserving …

Borderline ovarian tumor (BOT) is a heterogeneous group of tumors characterized by low
malignant potential and atypical proliferation, consisting of 15–20% of all primary ovarian …

Background/Aim: Borderline ovarian tumors (BOT) are malignant epithelial ovarian tumors
with a very low incidence, therefore lacking sufficient clinical experience in diagnostics and …